News Conference News ESC 2022 ‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR Shelley Wood August 28, 2022
News Daily News Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’ Michael O'Riordan July 18, 2022
News Daily News hs-Troponins and the Chest Pain Guidelines: Experts Call for Clarification Yael L. Maxwell July 08, 2022
News Daily News Subclinical Thrombosis After TAVI Benign, at Least to 3 Years Michael O'Riordan June 07, 2022
News Conference News EuroPCR 2022 CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial Yael L. Maxwell May 24, 2022
News Daily News Coronary Plaque Seen in Half of Asymptomatic Individuals on CTA Yael L. Maxwell May 16, 2022
Presentation ARCH 2022 CT/FFRct/FFRangio: Effect on Modern Cath Lab Presenter: George S. Chrysant April 23, 2022
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Conference News ACC 2022 FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses Michael O'Riordan April 06, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Daily News Deep-Learning Tool Can Gauge Plaque Burden, Stenosis Severity on CCTA Yael L. Maxwell March 28, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Daily News Absence of CAC May be Protective Even in Patients With Very High Cholesterol Michael O'Riordan February 14, 2022
News Daily News Optimal Medical Therapy for Stable Angina: Which Drugs? How Long? Michael O'Riordan January 25, 2022
News Daily News TCTMD’s Top 10 Most Popular Stories for December 2021 Caitlin E. Cox December 29, 2021
News Opinion Editor's Corner Glancing Back, Looking Forward: Lasting Lessons for Years to Come Shelley Wood December 27, 2021
News Daily News Black Patients With Chest Pain Differ From Whites, but Risks Are Similar Michael O'Riordan December 23, 2021
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021